Frost and Sullivan: Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market
September 24, 2019
September 24, 2019
SAN ANTONIO, Texas, Sept. 24 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
The need for improved immunogenicity, delivery technologies and reliable supply are driving the shift from the traditional vaccine model toward a more pharma-like model. The vaccine market was worth $33.57 billion in 2018 and accounted for 2.7% of the pharmaceutical ma . . .
The need for improved immunogenicity, delivery technologies and reliable supply are driving the shift from the traditional vaccine model toward a more pharma-like model. The vaccine market was worth $33.57 billion in 2018 and accounted for 2.7% of the pharmaceutical ma . . .